Factors effecting efficacy in anti-TNF therapy in clinical practice: Experiences from national registry ATTRA

Abstract

This study characterized response to the first trial of antitumour necrosis factor (TNF) drugs among rheumatoid arthritis (RA) patients in the Czech registry of biological therapy (ATTRA)

Keywords

• rheumatois arthritis
• biological DMARDs
• anti-TNF
• etanercept
• monoclonal antibodies